Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
about
The Role of Oxidative Damage in the Pathogenesis and Progression of Alzheimer's Disease and Vascular DementiaPON1 and Mediterranean DietModulation of paraoxonases during infectious diseases and its potential impact on atherosclerosisPaired measurements of paraoxonase 1 and serum amyloid A as useful disease markersModulation of paraoxonase 1 and 3 expression after moderate exercise training in the ratSerum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population.Studies on HDL associated enzymes under experimental hypercholesterolemia: possible modulation on selenium supplementation.Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairmentThe assessment of carotid intima media thickness and serum paraoxonase-1 activity in Helicobacter pylori positive subjects.Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular riskParticipation of ATP7A in macrophage mediated oxidation of LDL.Paraoxonase1 genetic polymorphisms in a mixed ancestry African populationSerum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows.Lead exposure is associated with decreased serum paraoxonase 1 (PON1) activity and genotypesEffects on transcriptional regulation and lipid droplet characteristics in the liver of female juvenile pigs after early postnatal feed restriction and refeeding are dependent on birth weight.Interactions between paraoxonase 1 genetic polymorphisms and smoking and their effects on oxidative stress and lung cancer risk in a Korean population.PON3 knockout mice are susceptible to obesity, gallstone formation, and atherosclerosisParaoxonase-3 is depleted from the high-density lipoproteins of autoimmune disease patients with subclinical atherosclerosis.Regulation of hepatic paraoxonase-1 expression.PON-1 Activity and Plasma 8-Isoprostane Concentration in Patients with Angiographically Proven Coronary Artery DiseaseThe concentration of thiobarbituric acid reactive substances (TBARS) and paraoxonase activity in blood of patients with osteoarthrosis after endoprosthesis implantationRelationship of human paraoxonase-1 serum activity and genotype with atherosclerosis in individuals from the Deep SouthPomegranate for your cardiovascular healthThere is no relationship between Paraoxonase serum level activity in women with endometriosis and the stage of the disease: an observational study.Abundance of plasma antioxidant proteins confers tolerance to acute hypobaric hypoxia exposure.New roles of HDL in inflammation and hematopoiesis.Role of PON in anoxia-reoxygenation injury: a Drosophila melanogaster transgenic model.Acetylcholinesterase/paraoxonase genotype and expression predict anxiety scores in Health, Risk Factors, Exercise Training, and Genetics studyMolecular biology of atherosclerosis.Atherogenesis: hyperhomocysteinemia interactions with LDL, macrophage function, paraoxonase 1, and exercise.A review of paraoxonase 1 properties and diagnostic applications.Assessment of the relationship between serum paraoxonase activity and epicardial adipose tissue in hemodialysis patients.Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity.Cholesterol reduction and macrophage function: role of paraoxonases.Formaldehyde induces neurotoxicity to PC12 cells involving inhibition of paraoxonase-1 expression and activity.Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS.The catalytic histidine dyad of high density lipoprotein-associated serum paraoxonase-1 (PON1) is essential for PON1-mediated inhibition of low density lipoprotein oxidation and stimulation of macrophage cholesterol efflux.Serum paraoxonase activity, total thiols levels, and oxidative status in patients with acute brucellosis.Paraoxonase is reduced in patients with growth hormone deficiency: A novel risk factor for atherosclerosis.Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization
P2860
Q26795415-C23F6DB6-96D2-4CFD-9117-44ABA10D4F31Q26824686-5117B699-675B-4AE2-B0E1-9EE8C2E4010AQ27004131-C27DDA49-6B77-48A2-8662-E7A2C2EB6D8FQ27006749-A50B16A0-0AD8-4808-B813-C474B5A622C8Q28566625-15FE5E6C-5F90-4943-92BB-934D5CC72FE4Q33278805-A250BF9E-76E4-47A3-ADB1-04B796EA3C63Q33587302-B7C6729B-3837-4567-855F-A11EAF3C38C6Q33878870-D7B661A5-8E5D-412B-A177-8BF87BB83561Q34114349-92F5E181-97B2-4F11-ADF9-93C89D535125Q34457337-7BCA3AF0-9425-4CB3-81FB-9AFE8CC3849BQ34559932-A155401A-8F76-409E-B4CE-1A4389806924Q34590668-EC534BED-01E8-407E-A705-FD76524E802DQ34665004-B8DA46C7-3A2B-4AA8-8A52-E47315AA39CDQ35001794-DCCF6E11-722D-434C-8BC2-310148EAE60FQ35048017-C23C6D55-62A2-49A0-86C4-E5104B7213A3Q35151639-B4A226E6-FB3C-42CC-9ADF-DFC60201F9C0Q35410647-73B9B00E-683B-4FC8-AD18-1CAE4EA0D30EQ35615662-68BB4748-6F7D-4B68-912F-A2D934A3BEE3Q35882841-4F0DE461-D8DF-4C54-BD83-6A7B0CCF5E35Q36366974-23AA47EB-4157-4AB7-AAD2-D1BDEB8C1EB3Q36576648-14656E13-022F-46CB-8327-F69BCAFFD895Q36755341-1FE321CF-8664-4561-9C5D-26EF0B4D38E0Q36919245-69E940AB-B253-4E75-80A3-E670DEFE8882Q36996548-40B7E50E-3D14-4FD7-B0B8-A0A03A3C2C21Q37202581-057234AC-7760-4B30-957E-0E130723BF59Q37314961-063CC7F0-C678-48B8-AB0C-660B14F8C056Q37439214-263308D7-13AF-4B35-BA69-1BF78E3F09F1Q37681855-CD2CEA14-5BBF-4E35-8AB0-A50D5357909DQ38125279-2ED097F6-0D71-4DA0-A4F3-96E5FD197E69Q38724228-369690A6-104D-4175-95EE-CC3202353CD5Q38812792-0E116481-04C9-432E-B375-1C88EDE0FABFQ38853533-DA394368-CCE1-446F-97B7-2834CC9988D9Q39429336-CF70295B-DF37-43B8-B450-D9F4C55E5527Q39457518-5169BD46-8163-412B-887E-F4304E689D7FQ39603847-63A982A6-A7F2-4AE4-9C00-7EC246C98277Q39614144-1E402DD3-41CF-4311-B6D1-470490D0C15AQ40331033-2B7A5375-ED0F-4134-9AC5-3497F46DC7CAQ41468366-28296F5E-E337-428C-8749-BEA5862B211FQ41854438-41F216EA-222A-486F-B983-CB729C17A063Q42157061-8B27D880-A3F6-41F6-8FE4-F3BBA92FFC6E
P2860
Paraoxonase (PON1) deficiency is associated with increased macrophage oxidative stress: studies in PON1-knockout mice.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Paraoxonase (PON1) deficiency ...... studies in PON1-knockout mice.
@en
type
label
Paraoxonase (PON1) deficiency ...... studies in PON1-knockout mice.
@en
prefLabel
Paraoxonase (PON1) deficiency ...... studies in PON1-knockout mice.
@en
P2093
P1476
Paraoxonase (PON1) deficiency ...... studies in PON1-knockout mice.
@en
P2093
Diana M Shih
Michael Aviram
Mira Rosenblat
Orit Rozenberg
Raymond Coleman
P304
P356
10.1016/S0891-5849(02)01429-6
P577
2003-03-01T00:00:00Z